Northwestern Mutual Wealth Management
EWTX icon

Northwestern Mutual Wealth Management’s Edgewise Therapeutics EWTX Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$934 Buy
+23
New +$793 ﹤0.01% 3799
2026
Q1 		– Sell
-489
Closed -$12.1K – 4239
2025
Q4 		$12.1K Buy
+489
New +$9.82K ﹤0.01% 2923
2024
Q1 		– Sell
-100
Closed -$1.09K – 3637
2023
Q4 		$1.09K Buy
+100
New +$702 ﹤0.01% 3161

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Northwestern Mutual Wealth Management's EWTX Position: Q2 2026 in Review

Northwestern Mutual Wealth Management opened a new position in Edgewise Therapeutics (EWTX) in Q2 2026: 23 shares worth $934. The stake represents ﹤0.01% of the portfolio and ranks #3799 among its holdings. This is a return to the name: Northwestern Mutual Wealth Management previously reported a position in EWTX as recently as Q4 2025.

Northwestern Mutual Wealth Management first reported a position in EWTX in Q4 2023 and has held it in 3 quarters since. The position peaked at $12.1K in Q4 2025. 226 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Northwestern Mutual Wealth Management held 23 shares of Edgewise Therapeutics worth $934 as of Q2 2026.
  • Edgewise Therapeutics was a new Northwestern Mutual Wealth Management position in Q2 2026.
  • Edgewise Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3799 holding.
  • Northwestern Mutual Wealth Management first reported a position in Edgewise Therapeutics in Q4 2023 and has held it in 3 quarters since.
  • Northwestern Mutual Wealth Management's Edgewise Therapeutics position peaked at $12.1K in Q4 2025.
  • 226 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.